Regardless of secondary side-effects, we hypothesize that RARRES1 expression and functional activity might be lost in choriocarcinomas, supporting the concept that placental RARRES1 might act in a suppressive manner and in cases of choriocarcinoma as a tumor suppressor. This evidence concerns the gene RARRES1 and choriocarcinoma.